Woodline Partners’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
Other funds holding VOR
Woodline Partners's VOR Position: Q3 2026 in Review
Woodline Partners reduced its Vor Biopharma (VOR) stake by 49% in Q3 2026, selling an estimated $3.96M and leaving 194,242 shares worth $3.71M. The position accounts for 0.01% of the portfolio, ranked #796.
Woodline Partners first reported a position in VOR in Q1 2021 and has held it in 16 quarters since. The position peaked at $49.7M in Q1 2021. 105 funds tracked by Wall St. Rank hold VOR as of Q3 2026.
- Woodline Partners held 194,242 shares of Vor Biopharma worth $3.71M as of Q3 2026.
- Woodline Partners sold 185,481 Vor Biopharma shares in Q3 2026, an estimated $3.96M.
- Vor Biopharma made up 0.01% of Woodline Partners's portfolio in Q3 2026, its #796 holding.
- Woodline Partners first reported a position in Vor Biopharma in Q1 2021 and has held it in 16 quarters since.
- Woodline Partners's Vor Biopharma position peaked at $49.7M in Q1 2021.
- 105 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.
Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.